首页> 外国专利> Derivatives of N - (hetero) pyrrolidine aryl pyrazole - 4-yl pyrrolo 2,3-d pyrimidines and pyrrole - 3 - il pyrrolo 2,3-d pyrimidines as Janus Kinase Inhibitors and Pharmaceutical compositions containing them

Derivatives of N - (hetero) pyrrolidine aryl pyrazole - 4-yl pyrrolo 2,3-d pyrimidines and pyrrole - 3 - il pyrrolo 2,3-d pyrimidines as Janus Kinase Inhibitors and Pharmaceutical compositions containing them

机译:作为Janus激酶抑制剂的N-(杂)吡咯烷芳基吡唑-4-基吡咯并[2,3-d]嘧啶和吡咯3-il吡咯并[2,3-d]嘧啶的衍生物和含有它们的药物组合物

摘要

Jak Inhibitors, such as Selective inhibitors of JAK1, useful in the treatment of diseases associated with Jak, including, for example, inflammatory and Autoimmune Disorders and cancer.Claim 1: wherein is a compound of formula (1) or a pharmaceutically acceptable Salt or n-oxide thereof; where X is halogeno, cyano or; is CH or N; Z is Hydrogen, c1-4 alkyl, c1-4 alkyl fluoride or Fluorine; ar is aryl, heteroaryl c6-14, C1 C7 - 14 - 14, cicloalquilarilo fusi Held, heterocicloalquilarilo c6-14 merged, cicloalquilheteroarilo C2 14 mergedOr heterocicloalquilheteroarilo C2 14 merged, each of which is optionally substituted with 1, 2, 3, 4, 5 or 6 groups R1 selected independently; each R1 is independently selected from alkyl halogeno, cyano, Nitro, C1 - 6 - 6, haloalquilo C1, C2 alquenilo - 6, alkyd Quot C2 - C3 - cycloalkyl 6, 13, 14 cicloalquil C3 alkyl heterocicloalquilo C1 - C2 - 14 4Heterocicloalquil C2 14 c1-4 alkyl, aryl aryl C6 C6 - 14 - 14 - c1-4 alkyl, heteroaryl heteroaryl c1-3, c1-3 alkyl c1-4, ora, - S, - (= o) - (RB, S = o) 2rb, - S nrerf (= o) - C (= o) - RB, Orb, C (= o) - C (= o) - nrerf, OC (= o) - RB, OC (= o) - nrerf, nrerf, NRCC (= o) - RD, NRCC (= OR) ord - NRCC (= o) - NRD, NRCS (= o) - 2RD, and nrbs (= o) 2nrerf; where the alkyl C1 - 6 - 6, haloalquilo C1, C2 alquenilo - 6Alquinilo C2 and 6 are each optionally replaced with 1, 2, 3 or 4 groups A1A selected independently; and where the cycloalkyl C3 C3 - 14 - 14, cicloalquil c1-4 alkyl, heterocicloalquilo C2 C2 - 14 - 14, heterocicloalquil c1-4 alkyl, aryl aryl c6-14, C6 14 c1-4 alkyl, heteroar ILO c1-3, and heteroaryl c1-3 alkyl C1 - 4 are each optionally replaced with 1, 2,3 or 4 groups 2a selected independently, each is selected independently between A1A halogeno, cyano, Nitro, hydroxyl, c1-4 alkoxy, haloalcoxi c1-4, Alquiltio c1-4, alquilsulfinilo c1-4, alquilsulfonilo c1-4, amino, alquilamino c1-4, di - alquilamino C1 - 4 alquilcarbonilo, c1-4, Alcoxicarbonilo carboxy, c1-4, alquilcarbonilamino c1-4, di - alquilcarbonilamino c1-4,Alcoxicarbonilamino c1-4, alcoxicarbonil C1 - 4 - (c1-4 alkyl) amino alquilcarbamilo Carbamyl, c1-4, and di aiquilcarbamilo c1-4; each 2a is selected independently between halogeno, cyano, Nitro, hydroxyl, c1-4 alkyl, haloalquilo alquenilo C1 - C2 - 4, 4 alquinilo c2-4, c1-4 alkoxy, haloalcox I Alquiltio c1-4, c1-4, alquilsulfinilo c1-4, alquilsulfonilo c1-4, amino, alquilamino c1-4,Di - alquilamino c1-4, alquilcarbonilo c1-4, carboxy, alcoxicarbonilo c1-4, alquilcarbonilamino c1-4, di - alquilcarbonilamino c1-4, alcoxicarbonilamino c1-4, alcoxicarbonil C1 - 4 - (c1-4 alkyl) amino alquilcarbamilo Carbamyl, c1-4, and di alquilcarbamilo C1 - 4; each ra, RB, RC, RD, re, and RF is selected Independently between h, alkyl haloalquilo C1 C1 - 6, - 6, - 6 alquinilo alquenilo C2, C2 - 6Cycloalkyl C3 C3 - 7 - 7, cicloalquil c1-4 alkyl, heterocicloalquilo C2 C2 - 7 - 7, heterocicloalquil c1-4 alkyl, phenyl, phenyl alkyl C1 - 4, 7 - heteroaryl heteroaryl C1, C1 and C1 - 4 - 7 - Rent; where the alkyl haloalquilo C1 C1 - 6 - 6, 6 - alquinilo alquenilo C2 and C2 - 6 are each optionally its Replace with 1, 2,RX 3 or 4 groups selected independently; and where the cycloalkyl C3 C3 - 7 - 7, cicloalquil c1-4 alkyl, heterocicloalquilo C2 C2 - 7 - 7, heterocicloalquil c1-4 alkyl, phenyl, phenyl alkyl C1 - 4, 7 - heteroaryl heteroaryl C1, C1 C1 alkyl - 7 - - 4 are each optionally replaced with 1, 2, 3 or 4 groups ry selected independently; or any RC and Rd,Along with the unit to which they are United, they form a ring heterocicloalquilo 3, 4, 5, 6 or 7 members, where the ring heterocicloalquilo is optionally substituted with 1, 2, 3 or 4 groups independently selected from hydroxyl, c1-4 alkyl, haloalquilo c1-4, alcox I haloalcoxi c1-4, c1-4, amino, alquilamino c1-4, and di - or any alquilamino c1-4, re and RFAlong with the nitrogen Atom to which they are United, they form a Ring heteroaryl or heterocicloalquilo 3, 4, 5, 6 or 7 members, where the heterocicloalquilo or heteroaryl ring is optionally substituted with 1, 2, 3 or 4 independently selected from hydroxyl groups C1-4 alkyl, haloalquilo c1-4 alkoxy, c1-4, haloalcoxi c1-4, amino, alquilamino c1-4,Di - and alquilamino c1-4; each RX is selected independently from hydroxyl, c1-4 alkoxy, amino, haloalcoxi c1-4, alquilamino c1-4, and di alquilamino c1-4; and every ry is selected independently from hydroxyl, halogeno, cyano, Nitro, c1-4 alkyl haloalquilo, c1-4 alkoxy, c1-4, Hal Oalcoxi c1-4, amino, alquilamino c1-4,Di - and alquilamino c1-4, provided that it does not exceed the value of each Atom in the units optionally substituted.
机译:雅克抑制剂,例如JAK1的选择性抑制剂,可用于治疗与雅克有关的疾病,包括例如炎性和自身免疫性疾病和癌症。权利要求1:其中式(1)的化合物或药学上可接受的盐或其正氧化物;其中X是卤素,氰基或;是CH或N; Z是氢,C 1-4烷基,C 1-4烷基氟或氟; ar是芳基,杂芳基c6-14,C1 C7-14-14,cicloalquilarilo fusi举行,杂cicloalquilarilo c6-14合并,cicloalquilheteroarilo C2 14合并或杂cicloalquilheteroarilo C2 14合并,每个都可选地被1,2、3、4、4取代独立选择5或6组R1;每个R 1独立地选自烷基卤代,氰基,硝基,C 1-6-6,卤代alquilo C 1,C 2烷基-6,醇酸基C 2 -C 3-环烷基6、13、14 cicloalquil C3烷基杂环氯基C1-C2-14 4杂邻氯基C2 14 c1-4烷基,芳基芳基C6 C6-14-14-c1-4烷基,杂芳基杂芳基c1-3,c1-3烷基c1-4,ora,-S,-(= o)-(RB,S = o)2rb,-S nrerf(= o)-C(= o)-RB,Orb,C(= o)-C(= o)-nrerf,OC(= o)-RB,OC(= o)- nrerf,nrerf,NRCC(= o)-RD,NRCC(= OR)ord-NRCC(= o)-NRD,NRCS(= o)-2RD和nrbs(= o)2nrerf;其中烷基C1-6-6,卤代烷基C1,C2alquenilo-6AlquiniloC2和6分别任选被1、2、3或4个独立选择的基团A1A取代;并且其中环烷基C3 C3-14-14,环氯基c1-4烷基,杂环氯基C2-142-4,杂环基c1-4烷基,芳基芳基c6-14,C6-14c1-4烷基,杂芳基ILO c1-3,杂芳基C 1-4烷基和C 1-4杂芳基分别被1、2、3或4个独立选择的基团2a取代,各自独立地选自A 1A卤代,氰基,硝基,羟基,c 1-4烷氧基,卤代烷氧基c 1-4, Alquiltio c1-4,alquilsulfinilo c1-4,alquilsulfonilo c1-4,氨基,alquilamino c1-4,di-alquilamino C1-4 alquilcarbonilo,c1-4,Alcoxicarbonilo羧基,c1-4,alquilcarbonilamino c1-4,di-alquilcarbonilamino c1 -4,Alcoxicarbililamino c1-4,Alcoxicarbonil C1-4-(c1-4烷基)氨基alquilcarbamilo Carbamyl,c1-4和di aiquilcarbamilo c1-4;每个2a独立地选自卤素,氰基,硝基,羟基,c1-4烷基,卤代alquinalquenilo C1-C2-4、4,Alquinilo c2-4,c1-4烷氧基,卤代醇I Alquiltio c1-4,c1-4,alquilsulfinilo c1-4,alquilsulfonilo c1-4,氨基,alquilaminoc1-4,Di-alquilamino c1-4,alquilcarbonilo c1-4,羧基,alcoxicarbonilo c1-4,alquilcarbonilamino c1-4,di-alquilcarbonilamino c1-4,alcoxicarbonilamino c1- 4,阿昔洛韦C1-4-(c1-4烷基)氨基阿卡帕米洛氨基甲酰基,c1-4和二阿卡帕米洛C1-4;每个ra,RB,RC,RD,re和RF均独立地选自h,烷基卤代alquilo C1-6--6--6 alquinilo alquenilo C2,C2-6环烷基C3 C3-7-7,cicloalquil c1-4烷基,杂环烷基C 2 -C 7-7,杂环基C 1-4烷基,苯基,苯基烷基C 1-4,7-杂芳基杂芳基C 1,C 1和C 1-4-7-;其中烷基卤代alquilo C1-6-6、6-alquinilo alquenilo C2和C2-6各自任选地被1、2,RX 3或4个独立选择的基团取代;且其中环烷基C3 C3-7,cicloalquil c1-4烷基,杂clocloalquilo C2-7-7,杂cicloalquilc1-4烷基,苯基,苯基烷基C1-4,7-杂芳基杂芳基C1,C1 C1烷基-7 --4个分别被分别选择的1、2、3或4个ry取代;或任何RC和Rd,与它们所连接的单元一起,形成3、4、5、6、7或7个成员的杂环杂环基,其中杂环杂环基可分别被1、2、3或4个独立选择的基团取代来自羟基,c1-4烷基,卤代alquilo c1-4,alcox I卤代alcoxi c1-4,c1-4,氨基,alquilamino c1-4和di-或任何alquilamino c1-4,re和RFAlong,带有氮原子它们是团结的,它们形成环杂芳基或杂环芳基3、4、5、6或7个成员,其中杂环芳基或杂芳基环任选地被1、2、3或4个独立地选自羟基C 1-4烷基,卤代芳基的取代基c1-4烷氧基,c1-4,卤代alcoxi c1-4,氨基,alquilamino c1-4,Di-和alquilamino c1-4;每个RX独立地选自羟基,c 1-4烷氧基,氨基,卤代alcoxi c 1-4,alquilamino c1-4和di alquilamino c1-4;且每个ry独立地选自羟基,卤代,氰基,硝基,c1-4烷基卤代alquilo,c1-4烷氧基,c1-4,Hal Oalcoxi c1-4,氨基,alquilamino c1-4,Di-和alquilamino c1-4 ,前提是该值不超过可选替换单位中每个Atom的值。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号